Rodger Novak

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Michael Esposito, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rodger Novak:

Company Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG President, Director Common Shares 573,007 $35,814,599 $62.50 30 Jun 2021 Direct

Insider Reports Filed by Rodger Novak

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRSP CRISPR Therapeutics AG 30 Jun 2021 1 -$4,125,000 4 President, Director 01 Jul 2021, 17:43
CRSP CRISPR Therapeutics AG 28 Jun 2021 1 -$3,913,750 4 President, Director 30 Jun 2021, 17:33
CRSP CRISPR Therapeutics AG 21 Jun 2021 6 -$3,215,458 4 President, Director 23 Jun 2021, 17:54